Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
about
Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogenStudies on anticancer activities of antimicrobial peptidesExpression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureThe guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expressionMatrix metalloproteinases: old dogs with new tricksMeta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer riskCyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancerActive stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinaseADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasionAnthocyanins from Vitis coignetiae Pulliat Inhibit Cancer Invasion and Epithelial-Mesenchymal Transition, but These Effects Can Be Attenuated by Tumor Necrosis Factor in Human Uterine Cervical Cancer HeLa CellsComprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator.Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome.Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivoSynergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesionsMatrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.Peptide aptamers as new tools to modulate clathrin-mediated internalisation--inhibition of MT1-MMP internalisation.Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.Viral oncolysis - can insights from measles be transferred to canine distemper virus?EGFR may couple moderate alcohol consumption to increased breast cancer risk.RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.MMP-1 expression has an independent prognostic value in breast cancer.The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Inflammatory transcriptome profiling of human monocytes exposed acutely to cigarette smoke.Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)Chemical proteomics: terra incognita for novel drug target profiling.QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasisClinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genisteinMMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.
P2860
Q24337919-1E818B03-8E74-439B-AF0C-CB602F0E967DQ24650885-7702A335-587C-4E73-BE3E-6DE7CCC988BDQ24652514-B7B46BBF-0A1B-459A-ADDF-BB0367DDBDADQ24671121-AF6C571B-5ACA-46E4-80C8-884235056D5AQ24795980-BBF5634B-8604-4CB0-9794-8BC619EFD1B5Q26771838-2D76AAA8-1136-48EB-B38D-2E862AB54215Q28167125-999EEB36-729A-44A5-B83E-29A02BF6235EQ28185337-8B2883DB-464B-4761-ADD5-0EB6738AB8CAQ28201376-10454C30-6C97-4537-BFC2-94D5AD23CBFFQ28270932-2D6BA84A-9B99-4A47-8EA5-C7F026DE41D8Q28385365-28288E53-0C6D-4AE2-9206-E978741E9B73Q33233386-6FDBA190-40F8-4317-BBAC-8F0709F1C10BQ33233428-0878C911-9534-4F9E-8CD7-7067466D0D9DQ33289231-C9BCCE14-CDCF-418B-BD04-2A1DD2BB484CQ33562717-D97FD876-7A4B-4900-AA76-4F37D073C9E9Q33598470-54957418-C088-423C-BE70-8EC54C0AD5ADQ33632650-EC6AB1F7-9DCE-4DDA-8092-7724F5F034B1Q33638905-84596879-97B1-4033-A305-F941E4D709C7Q33638953-64270215-1C1D-4213-99DC-FBA9FED33CD3Q33778640-E8B962D3-76E6-4B9D-B9D3-374BABD78F45Q33820267-0BA3550B-00AF-483F-89E4-F2CF50F39B29Q33820717-314BE6EA-07E1-4B69-81CC-1C5FA590C37BQ33858538-78917346-41E3-4EA6-B528-B2F84061DD04Q33946429-8C96F30D-6247-4FA8-B0C3-A0FE45CB65DDQ33947759-5AEF2C62-D7B0-41DC-A34E-15ED34A15DF1Q33980773-EEDC9EF8-EBA3-43A1-AC9C-CD4B8811CAEDQ33991012-B7BE54CC-24CD-4A7D-BD42-DD12076EF8A3Q34084897-D400F890-E8E1-4AD4-8B03-E56FEC0BAE94Q34155848-E3783E9F-79C6-4403-8FF9-C9C0D7F5D3C0Q34169904-B03203B4-A8A0-4882-A519-EE2960C0510CQ34256198-62A74130-8165-4209-9896-A88F60C2881DQ34284580-A1ACB87B-3105-480D-AD30-36FC59CC1B10Q34289671-E83263DD-5885-4AA9-A3DA-730FDE7EDF3EQ34293732-B71CDBA1-598F-4C0D-AED5-6685C87E692FQ34348691-A13D9D35-D7BA-4FE2-842A-10ED1D591132Q34391559-0F6FECB5-8FED-446E-B3F7-8D990F6CEE15Q34604748-2850C1ED-1456-4694-AE8B-7C1FEB7E8A7EQ34770095-879D6511-5B6D-4711-844F-38098BF2E659Q34997415-5F2D1AE8-1C36-473A-BC47-85252AF48C87Q35005158-D70D6AB6-BF55-4CF6-97EB-1A6BEA37303D
P2860
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@ast
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@en
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@nl
type
label
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@ast
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@en
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@nl
prefLabel
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@ast
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@en
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
@nl
P2860
P356
P1476
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets
@en
P2093
Veli-Matti Kähäri
P2860
P304
P356
10.1002/IJC.10329
P50
P577
2002-05-01T00:00:00Z